Benefits
Healthy Blood Sugar Levels
Chromium is component of glucose tolerance factor (GTF) — supports insulin function. Multiple trials of ChromeMate show modest improvements in fasting glucose, HbA1c, and glucose tolerance.
Lipid Profile Support
ChromeMate trials show modest reductions in total cholesterol and LDL cholesterol, with HDL increases in some studies.
Weight Management Adjunct
Chromium supports normal glucose handling which may help reduce sugar cravings and support weight management. Modest weight effects in trials.
Insulin Sensitivity
Chromium is essential for insulin function; supplementation may improve insulin sensitivity in deficient or insulin-resistant individuals.
Niacin-Bound Form Distinction
Niacin (vitamin B3) chelation distinguishes from chromium picolinate; provides chromium with cofactor support; some evidence for improved bioavailability.
Mechanism of action
Glucose Tolerance Factor (GTF) Component
Chromium is essential component of GTF — endogenous insulin-enhancing factor in human body. Adequate chromium supports insulin signaling.
Insulin Receptor Sensitivity
Chromium enhances insulin receptor activity and signaling; mechanism for blood sugar effects.
Niacin Cofactor Activity
Niacin (B3) component contributes additional metabolic effects — niacin itself has documented lipid effects (especially HDL increase) at high doses.
Niacin-Chromium Synergy
Niacin-bound form may offer synergistic effects on lipid metabolism and glucose handling vs chromium alone.
Clinical trials
Multiple ChromeMate clinical studies on glucose, insulin, and lipid markers.
Adults with metabolic concerns including type 2 diabetes adjunct.
Modest improvements in glucose handling, insulin sensitivity, and lipid markers.
Multiple chromium supplementation trials in glucose intolerance and type 2 diabetes.
Various populations.
Modest glucose handling improvements; effect size variable; bioavailable forms more reliable.